Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial

BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...

Full description

Saved in:
Bibliographic Details
Published in:J Vet Intern Med
Main Authors: Vincent, Alysha M., Okonkowski, Linda K., Brudvig, Jean M., Refsal, Kent R., Berghoff, Nora, Olivier, N. Bari, Langlois, Daniel K.
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2021
Subjects:
SMALL ANIMAL
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/
https://ncbi.nlm.nih.gov/pubmed/34114259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items